ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 238 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2013. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,234,326 | +3.9% | 170,040 | -0.3% | 0.00% | 0.0% |
| Q2 2023 | $2,150,001 | -3.2% | 170,635 | +0.3% | 0.00% | 0.0% |
| Q1 2023 | $2,219,962 | -32.4% | 170,112 | -8.6% | 0.00% | 0.0% |
| Q4 2022 | $3,283,951 | +15.8% | 186,165 | -0.1% | 0.00% | 0.0% |
| Q3 2022 | $2,837,000 | +2.3% | 186,294 | -0.3% | 0.00% | 0.0% |
| Q2 2022 | $2,772,000 | -34.4% | 186,910 | -0.4% | 0.00% | -50.0% |
| Q1 2022 | $4,227,000 | +11.3% | 187,693 | -8.8% | 0.00% | +100.0% |
| Q4 2021 | $3,797,000 | +30.6% | 205,818 | -5.4% | 0.00% | 0.0% |
| Q3 2021 | $2,908,000 | -33.6% | 217,520 | -8.1% | 0.00% | -50.0% |
| Q2 2021 | $4,379,000 | -0.0% | 236,570 | -18.9% | 0.00% | 0.0% |
| Q1 2021 | $4,380,000 | +7.9% | 291,675 | +3.7% | 0.00% | 0.0% |
| Q4 2020 | $4,060,000 | +77.4% | 281,180 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $2,289,000 | +18.5% | 281,180 | -1.5% | 0.00% | 0.0% |
| Q2 2020 | $1,932,000 | -36.8% | 285,370 | -34.3% | 0.00% | -50.0% |
| Q1 2020 | $3,056,000 | -28.5% | 434,080 | -0.3% | 0.00% | 0.0% |
| Q4 2019 | $4,273,000 | -11.6% | 435,330 | -1.2% | 0.00% | -33.3% |
| Q3 2019 | $4,836,000 | -6.5% | 440,430 | -1.0% | 0.00% | 0.0% |
| Q2 2019 | $5,174,000 | +15.3% | 444,895 | -5.4% | 0.00% | 0.0% |
| Q1 2019 | $4,487,000 | -1.6% | 470,295 | -0.6% | 0.00% | 0.0% |
| Q4 2018 | $4,560,000 | +2.0% | 473,065 | +50.8% | 0.00% | 0.0% |
| Q3 2018 | $4,472,000 | +26.9% | 313,799 | +6.8% | 0.00% | +50.0% |
| Q2 2018 | $3,525,000 | -35.4% | 293,769 | -33.5% | 0.00% | -50.0% |
| Q1 2018 | $5,453,000 | -15.1% | 441,514 | -0.0% | 0.00% | -20.0% |
| Q4 2017 | $6,424,000 | +54.8% | 441,534 | +51.4% | 0.01% | +66.7% |
| Q3 2017 | $4,151,000 | +11.4% | 291,724 | -0.1% | 0.00% | 0.0% |
| Q2 2017 | $3,725,000 | +118.2% | 291,954 | +116.9% | 0.00% | +200.0% |
| Q1 2017 | $1,707,000 | +19.8% | 134,614 | -3.5% | 0.00% | 0.0% |
| Q4 2016 | $1,425,000 | -24.1% | 139,524 | -2.1% | 0.00% | -50.0% |
| Q3 2016 | $1,877,000 | +2.6% | 142,534 | -1.1% | 0.00% | 0.0% |
| Q2 2016 | $1,830,000 | -7.5% | 144,064 | -3.8% | 0.00% | 0.0% |
| Q1 2016 | $1,979,000 | -14.3% | 149,794 | -0.3% | 0.00% | 0.0% |
| Q4 2015 | $2,310,000 | +22.9% | 150,174 | -0.9% | 0.00% | 0.0% |
| Q3 2015 | $1,879,000 | -9.3% | 151,564 | +0.1% | 0.00% | 0.0% |
| Q2 2015 | $2,072,000 | +21.4% | 151,444 | +6.1% | 0.00% | +100.0% |
| Q1 2015 | $1,707,000 | -15.2% | 142,714 | -9.4% | 0.00% | -50.0% |
| Q4 2014 | $2,012,000 | -52.1% | 157,574 | -49.6% | 0.00% | -50.0% |
| Q3 2014 | $4,197,000 | -16.3% | 312,864 | +0.2% | 0.00% | 0.0% |
| Q2 2014 | $5,012,000 | -12.0% | 312,244 | -1.2% | 0.00% | -20.0% |
| Q1 2014 | $5,696,000 | +121.9% | 315,936 | +90.3% | 0.01% | +150.0% |
| Q4 2013 | $2,567,000 | -0.7% | 166,056 | -4.4% | 0.00% | -33.3% |
| Q3 2013 | $2,584,000 | +30.1% | 173,746 | +13.2% | 0.00% | +50.0% |
| Q2 2013 | $1,986,000 | – | 153,467 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |